Back to Search
Start Over
Alexza Pharmaceuticals submits European MAA for Adasuve for schizophrenia or bipolar disorder treatment
- Source :
- M2 Communications. October 28, 2011
- Publication Year :
- 2011
-
Abstract
- Oct 28, 2011 (M2 EQUITYBITES via COMTEX) -- Pharmaceutical company Alexza Pharmaceuticals Inc (Nasdaq:ALXA) revealed on Thursday the submission of its ADASUVE Marketing Authorisation Application (MAA) to the European Medicines [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Communications
- Publication Type :
- News
- Accession number :
- edsgcl.270968402